Associate Editor, Ophthalmology Times
Alembic pharmaceuticals announces USFDA Final Approval for brimonidine tartrate ophthalmic solution 0.15%.April 1st 2023
Brimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma.
COPHy 2023: Debating the value of home monitoring as a management option for AMDMarch 25th 2023
The various aspects of home monitoring for patients with age-related macular degeneration are discussed in this point/counterpoint by Prof. Rufino Silva, University of Coimbra / Coimbra Hospital and University Centre, Portugal, and Univ.-Prof. Dr. med. Robert P. Finger, PhD, Department of Ophthalmology, University of Bonn, Germany, during the 14th annual Congress on Controversies in Ophthalmology in Lisbon, Portugal
COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye diseaseMarch 25th 2023
Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, USA, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
OKYO Pharma announces customs clearance of GMP packaged OK-101 drug to be used in phase 2 clinical trial for treating dry eye diseaseFebruary 28th 2023
The company is anticipating the first patient-first visit in Q1 2023 and is looking to release top-line data from the Phase 2 trial in Q4 2023.
ARVO announces recipients of 2023 Pfizer Ophthalmics Carl Camras Translational Research AwardJanuary 26th 2023
The intent of the award is to recognize early-career researchers who have exhibited excellence in research, as well as their fundamental scientific discoveries, concepts and novel technologies which have led to, or have the promise of leading to, clinical application.
ARVO announces 2023 recipient of Genentech Career Development Award for Underrepresented Minority Emerging Vision ScientistsJanuary 21st 2023
The Genentech Award is intended to provide early-career underrepresented minority investigators with an opportunity to explore novel and innovative research project ideas.